Re: Salary [$1000 /week]

Dear gustavo.braslavsky.clinical,

We are looking for employees working remotely.

My name is Toby, I am the personnel manager of a large International company.
Most of the work you can do from home, that is, at a distance.
Salary is $2300-$5900.

If you are interested in this offer, please visit Our Site

d_health Good day!

► Новое занятие #3 в тренинге группы «Стратегия Short Squeeze»

Александр!

Вам доступно занятие #3 «Практика торговли по стратегии Short Squeeze»
(автор — Info-DVD )

Перейдите на страницу тренинга в группе «Стратегия Short Squeeze»:

https://www.infoclub.info/group/short_squeeze/training/lesson/427

С уважением, команда Инфоклуба
Поддержка: https://www.infoclub.info/contact

–––––––––––––––

Вы получили это сообщение, как зарегистрированный участник
Инфоклуба. Изменить настройки емэйл-уведомлений Вы можете в
личном профиле Инфоклуба: https://www.infoclub.info/support7

【Traicy通信】ジェットスター・ジャパン、夏スケジュール全26路線の航空券発売開始...

2018年01月19日号 / 708号

  おはようございます。    いつも、Traicyをご購読いただきありがとうございます!  

アクセスランキング

ジェットスター・ジャパン、夏スケジュール全26路線の航空券発売開始
出発2日前購入でも往復5万円以下! 香港航空で香港に行ってきた【搭乗レポート】
ピーチ、国内線で48時間セール 片道1,500円から
AIRDO、札幌/千歳〜岡山線を廃止 3月24日で
香港エクスプレス、MEGAセール開催中 東京・大阪・福岡発着が片道3,280円から
タイガーエア・台湾、茨城~台北/桃園線でプログラムチャーター便 夏ダイヤ中週2便
タイガーエア・台湾、JCBカード利用で日台線往復が最大15%割引
中国で発行する「ANA CARD」のサービス終了 招商銀行の提携終了で

セール・特別運賃

香港エクスプレス航空、8路線対象の「MEGAセール」第3弾 片道3,280円から

バス

路線バス自動運転化に向けた実証実験、茨城交通のバスで実施 パイオニアとみちのりHDら

新路線・増減便・運休

AIRDO、札幌/千歳〜岡山線を廃止 3月24日で
エバー航空、旭川〜台北/桃園線の運航再開 1月27日から3月14日まで
ANA、東京/羽田〜バンコク線を増便 6月1日から
タイガーエア・台湾、茨城~台北/桃園線でプログラムチャーター便 夏ダイヤ中週2便

テーマパーク

ドン・キホーテ道頓堀店の大観覧車「えびすタワー」、1月19日にリニューアルオープン

搭乗レポート

出発2日前購入でも往復5万円以下! 香港航空で香港に行ってきた【搭乗レポート】

Traicy Talk

new!東欧諸国でマイナーだけど、旅行におすすめの国は?
new! 北欧だったらノルウェーとスウェーデンどちらが見える確率が高いですか。
new!東欧諸国でマイナーだけど、旅行におすすめの国は?
new!イタリアに行きたいのですが...
new!中国に持っていってはいけないものはありますか。


Tribune Pulse - January 17 - 2018 Late Breaker Abstarct Submission now Open!

Webinar Liver Series Webinar, Transplantation Journal featured Article, Sandy Feng January 24 Webinar, In the News and more.

Email not displaying correctly? View it in your browser.



TTS Tribune Pulse  

TTS 2018 is now considering abstracts in the late-breaker and poster categories until FEBRUARY 15. 
It is anticipated that the compilation of late breaker abstracts is made possible by studies completed after the initial November 15, 2017 abstract submission deadline. They are intended to represent the very latest development in transplantation science. These abstracts will be reviewed in a very finite period by a special review board, and accepted with the same stringent criteria as the Nov 2017 abstract submissions. The review criteria will be at par with the original call for abstracts in Nov 2017, but for late-breaking abstracts there will be a stronger focus on the criteria of "very latest development in the field of transplantation".

 
Friday, January 19 Liver Series Webinar
 
Discussant:
Laura J. Wozniak, MD
Assistant Clinical Professor of Pediatrics in the Division of Gastroenterology, Hepatology, and Nutrition
UCLA, USA
 
 
Discussant:
Jacqueline O'Leary, MD, MPH
Medical Director of Research
Baylor Simmons TransplantInstitute, Dallas, USA
 
 
Click here to signup



Date and time: January 19th, 2018 2:00 PM EST (UTC-5 hours)

Topic: Antibody Mediated Rejection in Liver Transplantation Part I - Role of DSA's and Treatment Options

Description: Antibody mediated rejection (AMR) has become one of the hot topics in liver transplantation recently. In this webinar, world known experts in this topic will discuss the immunological, clinical aspects of AMR as well as available treatment options.

Format: Debate/Discussion


 
ALERT ... 
Upcoming Member Poll on 2022 Congress Venue

TTS Members will receive an email on January 22 asking for their opinion on the location of the 2022 Congress. Keep an eye out for the email!

FEATURED ARTICLE - Transplantation

Submitted by Dr Karen Keung, Editorial Fellow, Transplantation. 

DHRS9 Is a Stable Marker of Human Regulatory Macrophages.
Riquelme P, Amodio G, Macedo C, et al.
Transplantation. 2017 ;101(11):2731-2738.

Cellular therapy using human regulatory macrophages (Mregs) to promote immune regulation is under evaluation in early phase clinical trials in kidney transplantation.

In this study, the authors aimed to define a novel positive markers of human Mregs. A series of monoclonal antibodies (mAb) was generated by vaccinating mice with human Mreg lysates. A mAb clone (ASOT1) was found to react strongly with Mregs; immunoprecipitation and MALDI-MS sequencing identified dehydrogenase/reductase 9 (DHRS9) as the antigen. DHRS9 appeared as a promising specific and stable marker of human Mregs discriminating human Mregs from a panel of in vitro- derived macrophages in other polarization states.

Read the article
Webinar Announcement
Quality Assessment of Kidneys for Transplantation – Truth or Dare
Wednesday, January 24, 2018 - 12pm EST 
(9am San Francisco / 3pm Rio de Janeiro) 
 
Speaker:
Professor Sandy Feng, MD, PhD 
Professor of Surgery in Residence Director, Abdominal Transplant Surgery Fellowship University of California San Franciscos
 
 
Moderator:
Professor Eduardo Rocha, MD, PhD 

Professor of Nephrology Universidade Federal do Rio de Janeiro Rio de Janeiro, Brazil
 
 



Overview: The demand for kidney transplantation continues to rise inexorably as its life-saving and life-enhancing benefits are strongly established. The supply of kidneys remains sorely inadequate both in quantity and, very importantly, quality. These two factors combine to exert tremendous pressure to accomplish transplantation by aggressively utilizing all available deceased donor organs. This webinar will consider donor, recipient, transplant, and other relevant factors, as well as their potential interplay, that enter into the critical decision of whether to transplant or not to transplant.

 

  • Newly FDA-Approved Platform Will Rapidly "Manufacture" Stem Cells to Repair Our Bodies
  • This Doctor's Revolutionary Stem Cell Treatments Could Eradicate HIV
  • St. Jude Develops Gene Therapy for Severe Combined Immunodeficiency
  • Unraveling the Biocircuitry of Obesity
Follow us on Social Media